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Once a protein adopts the ﬁbrillar aggregate conformation, a seeding reaction becomes operative in
which pre-formed ﬁbrils function as seeds for soluble protein molecules to be ﬁbrillized. Such a
seeding reaction accelerates the protein ﬁbrillation in vitro; however, more investigation is required
to test the seeded ﬁbrillation inside cells. Here, we show that in vitro Cu,Zn-superoxide dismutase
(SOD1) ﬁbrils are transduced into cells and function as seeds to trigger the aggregation of endoge-
nously expressed SOD1. Seeded aggregation of mutant SOD1 will thus play roles in a molecular
pathomechanism of SOD1-linked amyotrophic lateral sclerosis.
Structured summary of protein interactions:
SOD1 and SOD1 bind by biophysical (View interaction)
SOD1 and SOD1 bind by cosedimentation in solution (View interaction)
SOD1 and SOD1 bind by transmission electron microscopy (View interaction)
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Misfolding of protein molecules often leads to the formation of
insoluble aggregates, among which ﬁbrillar aggregates with ap-
prox. Ten nanometer of the width are called amyloid [1]. Amyloid
is rich in b-sheet structures and constitutes an important structural
class of protein aggregates; actually, all proteins possess innate
propensities of forming a common amyloid structure [2]. Amyloid
formation in vivo has been observed as a major pathological
change in several diseases such as amyloidosis and neurodegener-
ative diseases [3]. Although it remains unclear whether amyloid is
a direct cause or a mere result of those diseases, a mechanism of
amyloid formation will help to understand a disease pathomecha-
nism in a molecular level.
Formation of amyloid-like ﬁbrillar aggregates has been pro-
posed to be described by a nucleation model, in which an unfavor-
able conformational transition of a protein molecule into the
nucleus triggers the protein ﬁbrillation [4]. Once the nucleation
completes, an aggregation process then enters into a ﬁbrilelongation step, where the ﬁbrillar aggregation drastically pro-
ceeds. In other words, a self-replicating property of a protein ﬁbril
propagates its ﬁbrillar structure; a preformed ﬁbril (or a nucleus)
acts as a structural template for as-yet-unaggregated soluble pro-
tein molecules to ﬁbrillate. This is well known as a seeding reaction
and is one of the features of amyloid-like aggregates. While a
seeded acceleration of protein ﬁbrillation has been reported in
many proteins in vitro (e.g. [4]), increasing numbers of studies
are now testing whether a seeding reaction occurs in in vivo
environment.
As one of pathologically important proteins with aggregation
propensities, we have so far noted Cu,Zn-superoxide dismutase
(SOD1), a copper, zinc ions-bound enzyme that disproportionates
superoxide anion into oxygen and hydrogen peroxide [5]. Aggrega-
tion of mutant SOD1 in spinal cord has been characterized as a
major pathological change in a subset of the familial form of amyo-
trophic lateral sclerosis (fALS) [6]. Recently, in vitro SOD1 aggre-
gates formed by addition of triﬂuoroethanol (TFE) have been
reported to penetrate inside cultured neuronal cells by macropin-
ocytosis and then nucleate aggregation of the soluble mutant
SOD1 proteins in the cells [7]. While TFE-induced SOD1 aggregates
exhibit less amyloid-like tinctorial properties with both ﬁbrillar
and granular morphologies [8,9], a seeding reaction plausibly
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Furthermore, the presence of misfolded mutant SOD1 in the cyto-
plasm is associated with conformational conversion of wild-type
SOD1 into its protease-sensitive misfolded form [10]. It is thus
plausible that misfolded forms of mutant SOD1 exhibit seeding
activity to further facilitate the aggregation of mutant/wild-type
SOD1 in the intracellular environment.
Notably, SOD1 proteins form insoluble aggregates in several
other in vitro conditions [11]. Depending upon the experimental
conditions, the SOD1 aggregates appear to exhibit distinct molecu-
lar properties. While it is much controversial which in vitro condi-
tion(s) reproduces the formation of pathological SOD1 aggregates,
we have found that aggregation of SOD1 is easily provoked by
demetallation of the bound copper and zinc ions with reduction
of the conserved intramolecular disulﬁde bond in SOD1 [12].
Aggregates of apo and disulﬁde-reduced SOD1 (apo-SOD1SH) pos-
sess morphological and tinctorial properties that are similar to
those of amyloid. This is consistent with the in vivo observation
that the pathological inclusions in transgenic mice expressing
fALS-causing mutant SOD1 is positive for an amyloid-diagnostic
dye, thioﬂavin S [12,13]. Furthermore, we have revealed that a pro-
tease-resistant core structure of the apo-SOD1SH aggregates
in vitro resembles that of the SOD1 aggregates puriﬁed from the
pathological inclusions [14]. FALS mutations have been proposed
to decrease the afﬁnity of SOD1 for copper/zinc ions [15] and facil-
itate the reduction of the disulﬁde bond in SOD1 [16], which
increases the intracellular fraction of aggregation-prone apo-
SOD1SH species in the pathological conditions. Taken together,
the SOD1 aggregation starting from the apo-SOD1SH state will be
distinct from that induced by TFE and possibly describes an alter-
native pathway for formation of pathological inclusions in SOD1-
linked fALS cases. There is, however, no evidence to show that
the in vitro aggregates of apo-SOD1SH possess the seeding activity
in the intracellular environment.
In this study, we ﬁrst characterize an in vitro seeding reaction of
apo-SOD1SH ﬁbrillation and then show that intracellular aggrega-
tion of mutant SOD1 is triggered by transduction of in vitro apo-
SOD1SH ﬁbrils. Our results have thus supported that amyloid-like
aggregates formed from the apo-SOD1SH state act as seeds to prop-
agate the inclusion pathologies in the SOD1-linked fALS cases.2. Materials and methods
2.1. Puriﬁcation of mutant SOD1
Bacterial expression, puriﬁcation and refolding of SOD1 with
I149T mutation (SOD1I149T) were performed as described in a pre-
vious study [14]. An N-terminal His tag in refolded SOD1 was re-
moved with thrombin immobilized with agarose (Calbiochem)
and then used for the following experiments. Concentration of
puriﬁed SOD1 was spectroscopically determined from the absor-
bance at 280 nm with 5500 cm1 M1 of an extinction coefﬁcient.2.2. Characterization of SOD1 aggregation in vitro
For in vitro aggregation, 100 lM SOD1I149T in 100 mM Na–Pi/
100 mM NaCl/5 mM EDTA, pH 8.0 (called NNE buffer) was set in
a 96-well plate and shaken at 1200 rpm and 37 C. Protein aggrega-
tion generally increases the solution turbidity, which can be mon-
itored by measuring the absorbance at 405 nm. Aggregates were
collected as pellets by ultracentrifugation at 110000g for
30 min at 4 C. After resuspended in pure water, those aggregates
were sheared with sonication and then used as seeds.
For in vitro seeded aggregation, 100 lM SOD1I149T in an NNE
buffer was mixed with 10 lM (monomer-base) sonicatedSOD1I149T aggregates and left without agitation at 37 C. Seeded
aggregation of SOD1I149T was examined by ultracentrifugal frac-
tionation of the samples into soluble supernatant and insoluble
pellets and analyzed by SDS–PAGE. Morphologies of seeded aggre-
gates were examined by an electron microscope (1200EX, JEOL).
The aggregates were absorbed on 400-mesh grids coated by a
glow-charged supporting membrane and negatively stained with
1% uranyl acetate.
Fluorescent modiﬁcation of SOD1 aggregates have been per-
formed as follows; 60 lM (monomer-base) SOD1I149T aggregates
were mixed with 0.6 mM Alexa Fluor 555-C2 maleimide (Invitro-
gen) in PBS containing 5 mM TCEP and incubated at room temper-
ature in the dark for an hour. Aggregates were then washed twice
with PBS by ultracentrifugation at 110000g, 4 C for 30 min and
resuspended in PBS.
2.3. Preparation of Neuro2a cells stably expressing human SOD1
A Flp recombination target (FRT) sequence was introduced into
mouse neuroblastoma (Neuro2a) cells by using the Flp-inTM system
(Invitrogen), generating a Neuro2a/FRT cell line. Neuro2a cells sta-
bly expressing human SOD1I149T with a C-terminal HA tag was
then made by transfecting Neuro2a/FRT cells with a pcDNA™5/
FRT plasmid harboring SOD1I149T-HA cDNA and a pOG44 plasmid
(Invitrogen). Transfection was performed with Lipofectamine
2000 (Invitrogen), and the cells stably expressing SOD1I149T-HA
(Neuro2a-SOD1I149T-HA) were selected with 200 lg/ml hygromy-
cin. Cells were maintained in Dulbecco’s modiﬁed Eagle’s medium
(DMEM, Sigma) supplemented with 10% heat-inactivated FBS (Sig-
ma), 100 U/ml penicillin, 100 lg/ml streptomycin and 200 lg/ml
hygromycin at 37 C in an atmosphere containing 5% CO2 and
95% air.
2.4. Intracellular seeding of SOD1 aggregation
For transduction of proteins into cultured cells, we followed the
method in our previous study by using the BioPORTER protein
delivery reagent (Genlantis) [17]. On day 1, Neuro2a-SOD1I149T-
HA cells were seeded on each well of a four-well chamber slide
(Lab-Tek™ II-CC2™, Nunc) or a six-well plate coated with polyeth-
yleneimine in DMEM/10% FBS. On day 2, medium was then ex-
changed to Opti-MEM, and the cells were incubated for an hour.
0.5 lM soluble or aggregated SOD1 in vitro was prepared in
50 ll (for each well of a four-well chamber slide) or 150 ll (for
each well of a six-well plate), by which a dried ﬁlm of BioPORTER
(prepared from 5 ll) was dissolved. These mixtures were left at
room temperature for 10 min., and 450 ll (for a four-well chamber
slide) or 1350 ll (for a six-well plate) of Opti-MEM was then
added. Medium was further exchanged to this protein/BioPORT-
ER-containing Opti-MEM, and the cells were incubated for four
hours at 37 C. The culture medium was then changed to DMEM/
0.5% FBS supplemented with 5 mM N6,20-O-dibutyryl cAMP (Naca-
lai Tesque) for differentiating Neuro2a-SOD1I149T-HA cells. On day
3, transduced cells were ﬁxed for immunocytochemical analysis
or collected for biochemical analysis.
For immunostaining of intracellular SOD1I149T-HA, cells were
ﬁxed with 4% paraformaldehyde containing 0.12 M sucrose in
PBS for 10 min, permeabilized with 0.5% TritonX-100 in PBS for
5 min, and blocked with 0.1% BSA in PBS-T for 30 min. Cells were
then incubated with anti-HA-ﬂuorescein, high afﬁnity (3F10)
(1:100 dilution, Roche) in PBS for an hour, washed twice with
PBS-T, and then mounted onto glass slides. Confocal images with
a slice thickness of 1 mm were obtained by a laser scanning
microscope of LSM5 Exciter system (Carl Zeiss, Germany) using a
40 objective lens. Images were also obtained by using a ﬂuores-
cence microscope (Olympus IX70, LCPlan Fl).
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40 supplemented with a protease inhibitor cocktail, Complete,
EDTA-free (Roche) and lysed by sonication. Soluble supernatant
was obtained by ultracentrifugation at 110000g for 30 min at
4 C, and the insoluble pellets were washed once with PBS/1%
NP-40/Complete and solubilized with PBS/2% SDS. Soluble super-
natant and insoluble pellets were mixed with an SDS–PAGE sample
buffer and loaded on a 12.5% SDS–PAGE gel (PAGEL, ATTO) after
boiling for 5 min. Following electrophoresis, proteins were electro-
blotted on a 0.2 lm-PVDF membrane (Bio-Rad) and analyzed by
Western blotting using rabbit polyclonal anti-HA antibody (Y-11,
Santa Cruz Biotechnology, 1:1000) and ECL™ anti-rabbit IgG,
Horseradish Peroxidase linked F(ab0)2 fragment (from donkey, GE
Healthware, 1:3000). Blots were developed with the SuperSignal
West Dura (Pierce), and images were obtained using LAS1000 (FUJI
FILM).
3. Results and discussion
3.1. Seeded ﬁbrillation of apo-SOD1SH in vitro
SOD1 has been known to form ﬁbrillar aggregates, when copper
and zinc ions are dissociated and the disulﬁde is reduced [12]. To
prepare SOD1 ﬁbrils in vitro, SOD1 with a fALS-causing mutation,
I149T, (SOD1I149T) was ﬁrst demetallated by precipitation with
trichloroacetic acid and re-solubilized with a buffer containing a
metal chelator, EDTA. Also, a reductant, DTT, was added to keep
the disulﬁde reduced. Constant agitation (shaking at 1200 rpm)Fig. 1. In vitro seeded ﬁbrillation of SOD1 with a fALS-causing mutation, I149T. (A) 100 l
DTT, and the spontaneous aggregation was monitored by increase in the solution turbidi
37 C. 100 lM apo-SOD1I149T was incubated with or without 10 lM (i.e. 10%, monomer b
from the sample and then separated into a supernatant (s) and a pellet (p) fraction by u
SDS–PAGE gel. (C) Intensities of protein bands in (B) were quantiﬁed by densitometric an
incubation time. Filled and open circles represent the reaction with and without addition
transmission electron microscopy. A bar represents 0.2 lm.of apo-SOD1SH with I149T mutation increases the solution turbid-
ity, showing aggregation (Fig. 1A). As reported previously [14], the
SOD1I149T aggregates have increased the intensity of thioﬂavin T
ﬂuorescence and also induced the red-shift of Congo red absorp-
tion spectrum (data not shown), conﬁrming that in vitro SOD1I149T
forms amyloid-like aggregates.
To test if SOD1 ﬁbrillation can be triggered by a seeding reac-
tion, the SOD1I149T seeds were prepared by shearing spontaneous
SOD1I149T aggregates with ultrasonication. We expected that rela-
tively low melting temperature (42 C) of SOD1I149T ﬁbrillar
aggregates [14] indicate their fragility and thus facilitate shearing
of the aggregates. The sheared SOD1I149T aggregates were added
as seeds to the solution containing a soluble form of apo and disul-
ﬁde-reduced SOD1I149T, and the incubation was performed in the
absence of any agitation. As revealed by SDS–PAGE (Fig. 1B and
C), amounts of SOD1I149T in insoluble pellets increased after addi-
tion of SOD1I149T seeds, while no insolubilization of SOD1I149T
was observed in the absence of seeds. Furthermore, ﬁbrillar mor-
phologies of the seeded SOD1I149T aggregates were conﬁrmed by
a transmission electron microscopy (Fig. 1D). These results have
thus supported the in vitro seeded ﬁbrillation of SOD1I149T, and
we have next examined the seeding reaction of SOD1I149T in the
intracellular milieu.
3.2. Intracellular formation of insoluble SOD1 aggregates by seeding
Recently, we have successfully introduced in vitro aggregates of
TDP-43proteins into theculturedcellsbyusingprotein transductionM apo-SOD1I149T was shaken at 1200 rpm, 37 C in an NNE buffer containing 5 mM
ty at 405 nm. (B) A seeding reaction of SOD1I149T was examined without shaking at
ase) SOD1I149T aggregates prepared in (A). After indicated time, an aliquot was taken
ltracentrifugation at 110000g for 30 min. These fractions were analyzed by a 15%
alysis, by which a fraction of SOD1I149T in pellets was obtained and plotted against
of pre-formed ﬁbrils, respectively. (D) Seeded ﬁbrils of SOD1I149T were observed by
Fig. 2. Intracellular aggregation of SOD1I149T is induced by incubation with exogenously added SOD1I149T ﬁbrils in vitro. (A and B) Neuro2a cells stably expressing SOD1I149T-
HA was transduced with SOD1I149T ﬁbrils prepared in Fig. 1. Cells were immunostained by anti-HA-ﬂuorescein antibody (green) and observed with a ﬂuorescence microscope.
Inclusions were conﬁrmed as indicated with red arrows. (C) Without transduction of SOD1I149T ﬁbrils, SOD1I149T-HA is expressed diffusely throughout the cell, and no
inclusions were observed. In (A–C), we have also attempted the nuclear staining with either DAPI or Hoechst33342, both of which were, however, found to stain the
exogenously added SOD1I149T ﬁbrils inside and outside cells; therefore, nuclear staining was omitted. (D) Cells transduced with soluble SOD1I149T or SOD1I149T ﬁbrils were
lysed with a buffer containing 1% NP-40, fractionated into soluble supernatant (s) and insoluble pellets (p), and then analyzed by Western blotting with anti-HA antibody.
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in vitro SOD1 aggregates into Neuro2a cells transiently expressing
C-terminallyHA-taggedSOD1I149T (SOD1I149T-HA)with I149Tmuta-
tion. Even before transduction of exogenous SOD1 aggregates, how-
ever, spontaneous formationofHA-positive inclusionswasobserved
in some of the transfected Neuro2a cells, which has made it difﬁcult
to illuminate the seeded aggregation of SOD1I149T-HA (data not
shown). Transient transfection generally introducesmultiple copies
of plasmids into a cell, but the number of plasmids introduced is not
uniform among cells. Accordingly, spontaneous formation of
SOD1I149T-HA inclusions appears to occur in some of cells with high
level of protein expression. In order to avoid spontaneous formation
of SOD1 inclusions in the cell, intracellular expression level of
SOD1I149T-HAwas reduced by preparing stably-transfectedNeuro2a
cells harboring a single copy of SOD1I149T-HA cDNA in the genomic
DNA (Neuro2a-SOD1I149T-HA, see Section 2).
As expected, there were no HA-positive inclusions in Neuro2a-
SOD1I149T-HA cells probably due to the low level of the protein
expression. In contrast, HA-positive inclusions were observed,
when Neuro2a-SOD1I149T-HA cells were transduced with in vitro
ﬁbrillar aggregates of SOD1I149T (Fig. 2A and B) but not with soluble
SOD1I149T proteins (Fig. 2C). These observations are thus consistent
with the idea that exogenously added SOD1I149T ﬁbrils act as seeds
to facilitate the aggregation of endogenous SOD1I149T-HA proteins.
In SOD1-linked fALS cases, formation of pathological inclusions
has been known to associate with the reduced solubility of mutant
SOD1 in a buffer containing a detergent, NP-40 [18]. To test if a seed-
ing reaction decreases solubility of intracellular SOD1I149T-HA
proteins, Neuro2a-SOD1I149T-HA cells transduced with either solu-
ble or aggregated SOD1I149T in vitro were lysed in the presence of
NP-40, fractionated into soluble supernatant and insoluble pellets,
and then probedwith anti-HA antibody on aWestern blot. As shown
in Fig. 2D, upon transduction of SOD1I149T aggregates, we found sig-niﬁcant amounts of intracellular SOD1I149T-HA in the insoluble pel-
let fraction (right panel); in contrast, intracellular SOD1I149T-HA
remained mostly soluble when the cells were transduced with sol-
uble SOD1I149T (left panel). Taken together, therefore, exogenously
added SOD1 ﬁbrils have been found to act as seeds and trigger insol-
uble aggregation of endogenous SOD1 in the cell.
3.3. Co-localization of intracellular SOD1 inclusions with exogenously
added seeds
In order to further conﬁrm that the seeded aggregation pro-
ceeds inside the cell, we have attempted to visualize in vitro
SOD1I149T ﬁbrils that are transduced into the cell. For that purpose,
in vitro SOD1I149T ﬁbrils were ﬁrst modiﬁed with a thiol-speciﬁc
dye, Alexa Fluor 555-C2 maleimide (Alexa555). Given that
SOD1I149T ﬁbrils in vitro were prepared in the presence of a reduc-
tant, DTT, all four Cys residues in SOD1I149T are in the thiol state
and thus potentially modiﬁed with Alexa555. Insoluble SOD1I149T
ﬁbrils were mixed with Alexa555 and then washed/collected by
ultracentrifugation (see Section 2). To conﬁrm the modiﬁcation
with Alexa555, the ﬁbrils were resolubilized with 2% SDS and ana-
lyzed by SDS–PAGE. As shown in Fig. 3A, gel staining with Coomas-
sie brilliant blue (CBB) reveals multiple protein bands with
retarded electrophoretic mobility, among which the upper three
bands are ﬂuorescent upon UV irradiation. These data have thus
conﬁrmed that SOD1I149T ﬁbrils are covalently modiﬁed with
Alexa555.
As performed above by using protein transduction reagents,
Alexa555-modiﬁed SOD1I149T ﬁbrils were then introduced into
Neuro2a-SOD1I149T-HA cells. Observation by a confocal microscope
has again conﬁrmed the formation of HA-positive inclusions in the
transduced Neuro2a-SOD1I149T-HA cells (Fig. 3B, left panel);
importantly, these HA-positive inclusions are found to co-localize
Fig. 3. Intracellular seeded aggregation of SOD1I149T. (A) In vitro SOD1I149T ﬁbrils were modiﬁed with a red ﬂuorescent dye, Alexa555-C2-maleimide, and analyzed by SDS–
PAGE. The protein bands were stained with Coomassie brilliant blue (left) or visualized under UV light (right), conﬁrming the successful modiﬁcation with Alexa555 dyes. (B)
Neuro2a cells stably expressing SOD1I149T-HA were transduced with Alexa555-SOD1I149T ﬁbrils (red) prepared in vitro, ﬁxed, stained with an anti-HA-Fluorescein antibody
(green) and then observed using a confocal microscope. A merged image has shown clear co-localization of intracellular SOD1I149T-HA aggregates (green) with transduced
Alexa555-SOD1I149T ﬁbrils (red). A nucleus was indicated with ‘‘nuc’’. Aggregates with asterisks were Alexa555-SOD1I149T ﬁbrils that were not incorporated inside cells.
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right panels). These results thus provide clear evidence to show
the intracellular seeding reaction of SOD1I149T aggregation.
3.4. Pathological implications
A pathological change in ALS appears to be a focal process and
has been considered to spread throughout upper/lower motor neu-
rons [19–22]. As a molecular basis of such pathological propaga-
tion, increasing attention has been recently paid on a seeding
ability of protein ﬁbrillar aggregates [23]. Indeed, SOD1 has been
characterized as a ﬁbrillogenic protein [11], and insoluble SOD1
aggregates isolated from fALS-model mice [24] as well as in vitro
SOD1 aggregates [12,25] have been reported to function as efﬁ-
cient seeds to accelerate aggregation of recombinant SOD1 pro-
teins in vitro. More interestingly, there seems to be several types
of SOD aggregates with distinct structural and biochemical proper-
ties that depend upon the experimental conditions in vitro [11].
TFA-induced aggregates of SOD1 (possibly retaining its intramolec-
ular disulﬁde bond) have been previously shown to exhibit intra-
cellular activity as seeds, and in this study, we have further
shown that alternative aggregates formed from apo-SOD1SH also
function as efﬁcient seeds in cells. SOD1 may, therefore, be able
to adopt several ﬁbrillar conformations that exhibit seeding activ-
ity to a variable degree in the intracellular environment. Further-
more, we have previously found distinct structures of SOD1
ﬁbrils that depend upon types of pathogenic mutations [14]. In
addition to exogenous ﬁbrils of SOD1I149T, those of wild-type and
G37R-mutant SOD1 were capable of triggering the inclusionformation in cells (data not shown). Given that structural and bio-
chemical properties of seeds are supposed to be faithfully propa-
gated [4], initial seeds would play a primary role in determining
kinetic aspects of seeding reactions and also properties of ﬁnal
SOD1 aggregates in cells. Notably, phenotypes of fALS such as dis-
ease severity have been known to be quite heterogeneous among
patients with different mutations in SOD1 [26]; even within a
group of patients with the same mutations, onset and duration of
disease are variable [27]. While it remains to be further clariﬁed
if intracellular SOD1 aggregates are somehow transferred across
non-proliferating motorneurons [7], it is interesting to speculate
that the disease phenotypes of SOD1-linked fALS are determined
by the structure of mutant SOD1 seeds that form at the initial stage
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